Axogen, Inc. AXGN
Nasdaq · stock · Electromedical & Electrotherapeutic Apparatus · website · IPO 1986-12-17
Axogen, Inc. statistics & valuation
Market cap$2.4B
P / S10.6×
P / B18.5×
Net margin-7.0%
Return on equity-12.2%
FCF margin-1.3%
Net debt$12.8M
Enterprise value USD$2.4B
Earnings yield EBIT/EV-0.3%
Return on capital-4%
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 74.3% | 75.8% | 76.6% | 78.5% | 82.0% | 80.8% | 83.7% | 84.6% | 84.6% | 84.3% |
| Operating margin | -3.5% | -1.8% | -13.5% | -21.4% | -20.0% | -20.6% | -29.4% | -24.4% | -13.2% | -19.8% |
| Net margin | -7.0% | -5.3% | -13.7% | -20.9% | -21.2% | -21.2% | -27.3% | -26.7% | -17.3% | -35.1% |
| FCF margin | -1.3% | 0.8% | -12.3% | -26.1% | -32.4% | -28.1% | -23.0% | -28.8% | -17.1% | -29.6% |
| Return on assets | -7.1% | -4.9% | -11.0% | -14.8% | -13.0% | -11.8% | -18.8% | -14.0% | -17.7% | -31.1% |
| Return on equity | -12.2% | -9.6% | -22.7% | -28.7% | -24.0% | -19.3% | -22.0% | -15.2% | -41.5% | -96.6% |
| Debt / equity | 0.38× | 0.46× | 0.49× | 0.45× | 0.40× | 0.26× | 0.00× | 0.00× | 0.79× | 1.36× |
| Current ratio | 5.11 | 3.24 | 2.89 | 4.13 | 5.23 | 6.36 | 6.47 | 11.57 | 4.06 | 3.97 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.